Patent details

Basic Information

Publication number:

EP3458080

PCT Application Number:

EP2017062295

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP177290376

PCT Publication Number:

WO2017198877

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

POLYPEPTIDES MODULATING SIGLEC DEPENDENT IMMUNE RESPONSES

French Title of Invention:

POLYPEPTIDES SIGLEC DE MODULATION DES RÉPONSES IMMUNITAIRES DÉPENDANTES

German Title of Invention:

POLYPEPTIDMODULIERENDE SIGLEC-ABHÄNGIGE IMMUNREAKTIONEN

SPC Number:

Dates

Filing date:

22/05/2017

Grant date:

10/07/2024

EP Publication Date:

27/03/2019

PCT Publication Date:

23/11/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/07/2024

EP B1 Publication Date:

10/07/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

22/05/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/07/2024

 

 

Name:

Octapharma AG

Address:

Seidenstrasse 2, 8853 Lachen, Switzerland (CH)

Inventor

1

Name:

SOLECKA-WITULSKA, Barbara

Address:

Germany (DE)

2

Name:

KANNICHT, Christoph

Address:

Germany (DE)

3

Name:

KOHLA, Guido

Address:

Germany (DE)

4

Name:

WINGE, Stefan

Address:

Sweden (SE)

Priority

Priority Number:

16170690

Priority Date:

20/05/2016

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 38/00; A61K 38/36; A61K 38/37; C07K 14/755;

Publication

European Patent Bulletin

Issue number:

202428

Publication date:

10/07/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

02/06/2025

Annual Fee Number:

9

Annual Fee Amount:

115 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages